JPS5462327A - Remedy for dna virus infectious disease - Google Patents

Remedy for dna virus infectious disease

Info

Publication number
JPS5462327A
JPS5462327A JP12575277A JP12575277A JPS5462327A JP S5462327 A JPS5462327 A JP S5462327A JP 12575277 A JP12575277 A JP 12575277A JP 12575277 A JP12575277 A JP 12575277A JP S5462327 A JPS5462327 A JP S5462327A
Authority
JP
Japan
Prior art keywords
remedy
infectious disease
dna virus
virus infectious
eau
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP12575277A
Other languages
Japanese (ja)
Other versions
JPS5748048B2 (en
Inventor
Haruhiko Machida
Minero Saneyoshi
Chikao Nakayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Priority to JP12575277A priority Critical patent/JPS5462327A/en
Publication of JPS5462327A publication Critical patent/JPS5462327A/en
Publication of JPS5748048B2 publication Critical patent/JPS5748048B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To provide a low-toxic and safe remedy for the infectious disease of DNA virus such as herpes virus, containing 1-β-D-arabinofuranosyl-5-ethyluracil (EAU) as a main component.
CONSTITUTION: Remedy for DNA virus infectious disease, prepared to oral administration drug, injection, drops, ointment, O/W-type cream, etc., containing EAU as an active component. Dose: 10W1000 mg/kg, pref. 5W500 mg/kg, for diseases in the body, and 0.1W20 W/V%, pref. 0.5W10 W/V%, for drugs for non- oral administration, eye drops, ointment for local application, etc.
COPYRIGHT: (C)1979,JPO&Japio
JP12575277A 1977-10-21 1977-10-21 Remedy for dna virus infectious disease Granted JPS5462327A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12575277A JPS5462327A (en) 1977-10-21 1977-10-21 Remedy for dna virus infectious disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12575277A JPS5462327A (en) 1977-10-21 1977-10-21 Remedy for dna virus infectious disease

Publications (2)

Publication Number Publication Date
JPS5462327A true JPS5462327A (en) 1979-05-19
JPS5748048B2 JPS5748048B2 (en) 1982-10-14

Family

ID=14917924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12575277A Granted JPS5462327A (en) 1977-10-21 1977-10-21 Remedy for dna virus infectious disease

Country Status (1)

Country Link
JP (1) JPS5462327A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0552053U (en) * 1991-12-18 1993-07-09 積水化学工業株式会社 Eaves gutter connection structure

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0552053U (en) * 1991-12-18 1993-07-09 積水化学工業株式会社 Eaves gutter connection structure

Also Published As

Publication number Publication date
JPS5748048B2 (en) 1982-10-14

Similar Documents

Publication Publication Date Title
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
YU48583B (en) Process for preparation of the formulation in the form of pill for oral dosage
BG105173A (en) Novel salt form of pantoprazole
RU93036959A (en) FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
KR970705563A (en) (2-amino-6- (cyclopropylamino) -9H-purin-9-yl) -2-cyclopentene-1-methanol succinate -9H-Purin-9-yl) -2-cyclopentene-1-methanol Succinate as Antiviral Agent)
JPS57109721A (en) Carcinostatic agent
WO1996011005A3 (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
KR900011461A (en) Therapeutics using trypstatin as an active ingredient
EP0271151A3 (en) Azumolene dosage form
JPS5462327A (en) Remedy for dna virus infectious disease
JPS6416721A (en) Antioxidant
JPS5793913A (en) Enhancing agent for spermous vital power
JPS55122715A (en) Antidiabetic agent
KR910007528A (en) Use of Benzodiazepines and Phenylpyrylketone Derivatives
Hladovec et al. Oral contraceptives, methionine and endothelial lesion
JPS5759809A (en) Cardiotonic agent
JPS5498339A (en) Carcinostatic agent
JPS6442430A (en) Side effect remover for chemotherapeutic agent
JPS6438027A (en) Remedy for cancer
EP0347531A3 (en) Use of 1,3-dithiole-2-thione-derivatives in therapy of hepatic diseases